Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$184M |
| 2 |
NWLI
National Western Life Group, Inc. Class A
NWLI
|
+$132M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$131M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$129M |
| 5 |
KeyCorp
KEY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$174M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$167M |
| 3 |
Pfizer
PFE
|
+$108M |
| 4 |
Ross Stores
ROST
|
+$107M |
| 5 |
NetEase
NTES
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.48% |
| 2 | Healthcare | 14.26% |
| 3 | Financials | 9.91% |
| 4 | Technology | 9.83% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
GoDaddy
GDDY
$12.7B
| $1.9M | 0.01% |
59,095
-603,232
| -91% | -$18.3M |
|
652
AXIS Capital
AXS
$7.25B
| $1.89M | 0.01% |
33,602
+19,622
| +140% | +$1.08M |
|
653
Aramark
ARMK
$15.6B
| $1.88M | 0.01% |
+80,673
| New | +$1.84M |
|
654
Universal Insurance Holdings
UVE
$1.21B
| $1.84M | 0.01% |
+79,404
| New | +$2.19M |
|
655
Magna International
MGA
$18.1B
| $1.84M | 0.01% |
45,306
-103,612
| -70% | -$4.82M |
|
|
SJI
656
DELISTED
South Jersey Industries, Inc.
SJI
| $1.84M | 0.01% |
+78,118
| New | +$1.91M |
|
657
PUT
Seagate
STX
$180B
| $1.83M | 0.01% |
+50,000
| New | +$1.9M |
|
658
Renasant Corp
RNST
$3.79B
| $1.81M | 0.01% |
52,677
+17,089
| +48% | +$602K |
|
659
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.79B
| $1.81M | 0.01% |
15,000
+10,000
| +200% | +$1.42M |
|
|
BCRH
660
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $1.79M | 0.01% |
104,603
| – | – |
|
|
CLLS
661
Cellectis
CLLS
$321M
| $1.77M | 0.01% |
+57,162
| New | +$1.73M |
|
662
CALL
iShares MSCI Brazil ETF
EWZ
$8.07B
| $1.76M | 0.01% |
85,000
-615,000
| -88% | -$14.3M |
|
663
Energy Recovery
ERII
$398M
| $1.75M | 0.01% |
+247,751
| New | +$1.56M |
|
|
CLVS
664
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.75M | 0.01% |
+50,000
| New | +$3.22M |
|
665
Calumet Specialty Products
CLMT
$4.16B
| $1.7M | 0.01% |
85,200
-29,782
| -26% | -$736K |
|
666
CALL
Infosys
INFY
$47.9B
| $1.68M | 0.01% |
+200,000
| New | +$1.73M |
|
|
JNS
667
DELISTED
Janus Capital Group Inc
JNS
| $1.65M | 0.01% |
117,047
+59,497
| +103% | +$886K |
|
|
ATW
668
DELISTED
Atwood Oceanics
ATW
| $1.62M | 0.01% |
158,730
+142,730
| +892% | +$2.18M |
|
669
Texas Capital Bancshares
TCBI
$4.26B
| $1.62M | 0.01% |
32,804
-126,743
| -79% | -$6.91M |
|
670
Fulton Financial
FULT
$4.5B
| $1.62M | 0.01% |
124,425
-414,295
| -77% | -$5.56M |
|
671
CALL
Designer Brands
DBI
$297M
| $1.6M | 0.01% |
+67,100
| New | +$1.61M |
|
672
CALL
Fortinet
FTNT
$112B
| $1.56M | 0.01% |
+250,000
| New | +$1.8M |
|
673
CALL
Pinnacle West Capital
PNW
$11.8B
| $1.53M | 0.01% |
23,800
+2,800
| +13% | +$178K |
|
|
SAGE
674
DELISTED
Sage Therapeutics
SAGE
| $1.53M | 0.01% |
+26,250
| New | +$1.3M |
|
675
Semtech
SMTC
$11.3B
| $1.52M | 0.01% |
80,590
-191,766
| -70% | -$3.51M |
|
Similar funds
Dmitry Balyasny's Q4 2015 Portfolio in Review
As of Q4 2015, Dmitry Balyasny held 1,681 positions worth $14.4B, up 6.4% from $13.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $521M of net new capital in Q4 2015, opening 566 new positions and adding to 330 existing holdings. Its largest new stake was Alphabet (Google) Class A: 4,979,180 shares worth $194M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was United Parcel Service, an estimated $174M trimmed.
- Dmitry Balyasny's largest Q4 2015 buy was Alphabet (Google) Class A: 4,979,180 shares worth $194M.
- Dmitry Balyasny added most to Teva Pharmaceuticals in Q4 2015, an estimated $131M increase.
- Dmitry Balyasny's biggest Q4 2015 reduction was United Parcel Service, cutting an estimated $174M.
- Dmitry Balyasny fully exited Abbott in Q4 2015, selling an estimated $94.7M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $14.4B portfolio in Q4 2015.
- Dmitry Balyasny opened 566 new positions and closed 480 in Q4 2015.
- Dmitry Balyasny's portfolio value rose 6.4% quarter-over-quarter to $14.4B.
Based on Balyasny Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.